Heilongjiang ZBD Pharmaceutical Co., Ltd. (603567.SS)
CNY 10.6
(-0.19%)
CNY 10.6
(-0.19%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 720.88 Million CNY | -28.32% |
| 2022 | 1 Billion CNY | 37.16% |
| 2021 | 733.26 Million CNY | -23.58% |
| 2020 | 959.54 Million CNY | 33.21% |
| 2019 | 720.33 Million CNY | -40.85% |
| 2018 | 1.21 Billion CNY | 5.67% |
| 2017 | 1.15 Billion CNY | -16.93% |
| 2016 | 1.38 Billion CNY | 0.64% |
| 2015 | 1.37 Billion CNY | 83.1% |
| 2014 | 752.84 Million CNY | 3.08% |
| 2013 | 730.34 Million CNY | 8.19% |
| 2012 | 675.06 Million CNY | 21.63% |
| 2011 | 555.01 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 1.28 Billion CNY | 15.45% |
| 2024 Q1 | 683.32 Million CNY | -5.21% |
| 2024 Q2 | 1.11 Billion CNY | 62.51% |
| 2023 Q3 | 1 Billion CNY | -15.9% |
| 2023 Q4 | 720.88 Million CNY | -28.28% |
| 2023 FY | 720.88 Million CNY | -28.32% |
| 2023 Q1 | 1.18 Billion CNY | 17.38% |
| 2023 Q2 | 1.19 Billion CNY | 1.24% |
| 2022 Q1 | 823.9 Million CNY | 12.36% |
| 2022 FY | 1 Billion CNY | 37.16% |
| 2022 Q4 | 1 Billion CNY | 14.3% |
| 2022 Q3 | 879.93 Million CNY | 13.44% |
| 2022 Q2 | 775.69 Million CNY | -5.85% |
| 2021 FY | 733.26 Million CNY | -23.58% |
| 2021 Q2 | 1.33 Billion CNY | 20.99% |
| 2021 Q1 | 1.1 Billion CNY | 15.19% |
| 2021 Q4 | 733.26 Million CNY | -42.32% |
| 2021 Q3 | 1.27 Billion CNY | -4.94% |
| 2020 Q3 | 971.84 Million CNY | 6.04% |
| 2020 Q2 | 916.46 Million CNY | -10.77% |
| 2020 Q1 | 1.02 Billion CNY | 42.59% |
| 2020 FY | 959.54 Million CNY | 33.21% |
| 2020 Q4 | 959.54 Million CNY | -1.27% |
| 2019 Q3 | 1 Billion CNY | -5.67% |
| 2019 Q4 | 720.33 Million CNY | -28.66% |
| 2019 FY | 720.33 Million CNY | -40.85% |
| 2019 Q2 | 1.07 Billion CNY | -7.85% |
| 2019 Q1 | 1.16 Billion CNY | -4.61% |
| 2018 Q2 | 1.66 Billion CNY | 12.32% |
| 2018 Q3 | 1.64 Billion CNY | -1.46% |
| 2018 FY | 1.21 Billion CNY | 5.67% |
| 2018 Q4 | 1.21 Billion CNY | -25.87% |
| 2018 Q1 | 1.48 Billion CNY | 28.79% |
| 2017 Q2 | 1.31 Billion CNY | -4.28% |
| 2017 FY | 1.15 Billion CNY | -16.93% |
| 2017 Q4 | 1.15 Billion CNY | -11.99% |
| 2017 Q3 | 1.3 Billion CNY | -0.38% |
| 2017 Q1 | 1.37 Billion CNY | -1.02% |
| 2016 Q1 | 1.54 Billion CNY | 12.03% |
| 2016 FY | 1.38 Billion CNY | 0.64% |
| 2016 Q4 | 1.38 Billion CNY | -10.83% |
| 2016 Q3 | 1.55 Billion CNY | 0.17% |
| 2016 Q2 | 1.55 Billion CNY | 0.57% |
| 2015 Q1 | 795.71 Million CNY | 5.69% |
| 2015 FY | 1.37 Billion CNY | 83.1% |
| 2015 Q4 | 1.37 Billion CNY | 28.85% |
| 2015 Q2 | 951.28 Million CNY | 19.55% |
| 2015 Q3 | 1.06 Billion CNY | 12.46% |
| 2014 Q2 | 765.73 Million CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 Q4 | 752.84 Million CNY | 0.0% |
| 2014 FY | 752.84 Million CNY | 3.08% |
| 2013 FY | 730.34 Million CNY | 8.19% |
| 2012 FY | 675.06 Million CNY | 21.63% |
| 2011 FY | 555.01 Million CNY | 0.0% |